Skip to main navigation Skip to search Skip to main content

Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril

  • Shmuel Oren*
  • , Ehud Grossman
  • , Edward D. Frohlich
  • *Corresponding author for this work
  • Ochsner Health System
  • Barzilai Medical Center

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Reduction of left ventricular (LV) mass in hypertensive patients treated with angiotensin-converting enzyme inhibitors is related to reduction in mean arterial pressure and to blockade of renin-angiotensin. The decrease in LV hypertrophy is not associated with deterioration in LV systolic function; conversely, diastolic function improves significantly, relative to the degree of reduction in LV mass.

Original languageEnglish
Pages (from-to)93-96
Number of pages4
JournalAmerican Journal of Cardiology
Volume77
Issue number1
DOIs
StatePublished - 1 Jan 1996

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril'. Together they form a unique fingerprint.

Cite this